


€132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital?
Europe’s biotech ecosystem just notched a headline-grabbing win. Azafaros, a

Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
BioArctic, a Swedish biotechnology company renowned for its innovative approach

Innovative Study on Addiction by Mount Sinai and Rockefeller University
A recent study conducted by Mount Sinai in collaboration with
